Crossbow Selects First Development Candidate from its T-cell Engagers
05 Mar 2024 //
GLOBENEWSWIRE
Crossbow Therapeutics Launches with $80 Million in Series A Financing
11 Jul 2023 //
GLOBENEWSWIRE
05 Mar 2024 //
GLOBENEWSWIRE
11 Jul 2023 //
GLOBENEWSWIRE